Alabama files legal case against opioid manufacturer Purdue Pharma
Date: 2018-02-07   Author: Dhananjay Punekar  Category: #news

In what may seem to be a major jolt to the opioid manufacturing companies in the U.S., Alabama Attorney General Steve Marshall has filed a litigation in the Montgomery court against Purdue Pharma L.P., a pharmaceutical major headquartered in the U.S., holding it responsible for opioid epidemic in the state.

As per the legal suit, the drug manufacturer has been involved in deceptive marketing providing misleading information to both the patients & physicians about the uses of opioid as a powerful pain-killing drug. The attorney also claimed that the firm is involved in opioid marketing owing to the fact that it wants the drug to be prescribed not just for severe short-term pain, but also for lower back pain, headaches and even arthritis.

According to an article by the Daily News, nearly 13 states of the U.S. have filed legal suits against opioid drug companies based in the country. Alabama has been declared the first state in the country to prescribe the maximum number of painkilling drugs per capita. In 2015, Opioid had accounted for over 5.8 million prescriptions of the state at the rate of 1.2 prescriptions per person, the highest drug prescribing rate in the U.S.

Alabama’s attorney general affirms that Purdue Pharma was the sole defendant in the litigation being the largest opioid supplier in Alabama. The legal case claims monetary damages from the Connecticut-based drug manufacturing firm and seeks alterations to its marketing practices.

However, the director of Purdue Pharma has denied the state’s allegations and has asserted that the firm follows the guidelines of the CDC while prescribing opioids for severe pain. He also justified his claim by declaring that the Pharma giant had developed three of its first four FDA approved opioids with abuse-deterrent features. Furthermore, the firm also stated that it has collaborated with a law enforcement agency to ensure easy access to naloxone for reversing the impact of opioid overdose on the patients.

For the uninitiated, earlier in 2017, Purdue had funded an opioid overdose program in association with the National Sheriffs’ Association.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Humana & PE firm consortium to buy Curo Health for $1.4 billion
Author: Paroma Bhattacharya

A consortium consisting of the notable U.S. health insurer Humana along with PE firms Welsh, Carson, Anderson & Stowe and TPG Capital announced that they have reached an agreement to acquire Curo Health Services, a...


Bill 13 to ensure energy retailers attend to billing complaints pronto
Author: Paroma Bhattacharya

Under a new bill introduced in Alberta, Canada, electricity and gas retailers in the state will be liable to pay hefty fines if they fail to settle customer billing complaints. Bill 13 now gives the Alberta Utilities C...


Evonik launches RESOMER composite polymers for bone fixation devices
Author: Ojaswita Kutepatil

Evonik, one of the leading biodegradable bone graft polymers industry majors, has recently announced the launch of its very first product grade from a brand-new product line of RESOMER Composite polymers.